Chimeric anti-EGFR monoclonal antibody

· Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chimeric anti-EGFR monoclonal antibody, covering 2018-02-08 to 2018-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial [Phase 3]